Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Will These 3 Stocks Survive the Rest of 2016?
View:
Post by Arizona546 on Aug 16, 2016 7:09pm

Will These 3 Stocks Survive the Rest of 2016?

https://www.fool.ca/2016/08/16/will-these-3-stocks-survive-the-rest-of-2016/

There’s no guarantee these companies go bankrupt, especially Concordia, which could still easily recover.
Comment by Craigbad on Aug 16, 2016 7:19pm
Concordia Oh, how the mighty have fallen. A year ago, shares of Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) were flying high, trading around $100 each on the TSX. A year later they’re $12 each, representing a decline of nearly 90%. Two things hit Concordia. The first was Valeant’s fall from grace, which suddenly exposed some of the weaknesses of the business model ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities